Neovasc Inc. P/Operating CF

P/Operating CF of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including P/Operating CF growth rates and interactive chart. A valuation metric that measures the price of a stock compared to its operating cash flow per share. Operating cash flow (OCF) is the amount of cash generated by a company's normal business operations. It can be different from reported net income due to accrual accounting, that is expenses and revenues are recognized differently than cash is received. The cash going in and out of the business is what ultimately determines its financial health, so it's one of the most important metrics to watch. A low P/OCF ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. P/OCF ratio can be compared to different companies in the same industry or to a company’s own historical valuation.


Highlights and Quick Summary

Current P/Operating CF of Neovasc Inc. is -6.95 (as of December 31, 2021)
  • P/Operating CF for the quarter ending March 31, 2022 was -4.17 (a -39.96% decrease compared to previous quarter)
  • Year-over-year quarterly P/Operating CF decreased by -53.84%
  • Annual P/Operating CF for 2021 was -6.95 (a 112.52% increase from previous year)
  • Annual P/Operating CF for 2020 was -3.27 (a -45.38% decrease from previous year)
  • Annual P/Operating CF for 2019 was -5.99 (a 321.32% increase from previous year)
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical P/Operating CF of Neovasc Inc.

Most recent P/Operating CFof NVCN including historical data for past 10 years.

Interactive Chart of P/Operating CF of Neovasc Inc.

Neovasc Inc. P/Operating CF for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -4.17
2021 -6.95 -6.7 -9.04 -6.07 -6.95
2020 -3.27 -4.81 -4.13 -2.32 -3.27
2019 -5.99 -4.26 -6.33 -2.76 -5.99
2018 -1.42 -8.7 -8.78 -165.66 -1.42
2017 -0.4 -33.26 -28.36 -18.8 -0.4
2016 -17.47 -3.22 -3.18 -25.88 -17.47
2015 -49.15 -51.42 -88.84 -162.65 -49.15
2014 -138.93 -95.12 -268.55 -412.57 -138.93
2013 -165.81 -79.59 -115.11 -131.9 -165.81
2012 -230.71 -136.91 -71.56 -107.25 -230.71
2011 -26.85 -26.85

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.